ArticleJournal for immunotherapy of cancer2021

Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC.

Petra Ross-Macdonald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.